How did CORT's Q4 2024 earnings surprise impact its annual performance?
4/6/2025 04:20pm
Corcept Therapeutics (CORT) experienced a negative earnings surprise in Q4 2024, with an EPS surprise of -0.18, representing a 6.2% decrease from the previous quarter. This negative surprise likely had a dampening effect on CORT's annual performance, as it indicated that the company's actual performance for the year fell short of market expectations.
|code|Ticker|Name|Date|Net Income (FY) YoY|Net Income (FY)|market_code|
|---|---|---|---|---|---|---|
|CORT|CORT.O|Corcept Therapeutics|2020|12.5609199307716|1.06011E8|186|
|CORT|CORT.O|Corcept Therapeutics|2021|6.1323824886096725|1.12512E8|186|
|CORT|CORT.O|Corcept Therapeutics|2022|-9.86028156996587|1.01418E8|186|
|CORT|CORT.O|Corcept Therapeutics|2023|4.655978228716796|1.0614E8|186|
|CORT|CORT.O|Corcept Therapeutics|2024|33.04032410024496|1.41209E8|186|